Although medical treatment of COPD has advanced, nonadherence to medication regimens
poses a significant barrier to optimal management. Underuse, overuse, and improper use …

COPD is prevalent in Western society and its incidence is rising in the developing world.
Acute exacerbations of COPD, about 50% of which are unreported, lead to deterioration in …

Current guidelines recommend inhaled pharmacologic therapy as the preferred route of
administration for treating COPD. Bronchodilators (β2-agonists and antimuscarinics) are the …

Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating chronic obstructive pulmonary disease (COPD). Previous …

Purpose Special considerations in the selection of medication inhaler devices for elderly
patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting …

Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled
medications are the mainstay of pharmacological treatment of COPD, and are typically …

Background Chronic obstructive pulmonary disease (COPD) affects an estimated 14% of
adults in the United States between the ages of 40 and 79 years. This progressive disease is …

Adding a long-acting β2-agonist (LABA) by dry powder inhaler (DPI) to tiotropium provides
significantly increased and sustained bronchodilation in chronic obstructive pulmonary …

Inhalers and nebulisers are devices used for delivering aerosolised drugs in subjects with
Chronic Airflow Obstruction (CAO). This multicentre, cross-sectional observational study was …

Chronic obstructive pulmonary disease (COPD) is a treatable disease characterized by
progressive airflow limitation. Prevention of disease progression, improvement of symptoms …